| 2.9876 0 (0%) | 06-09 09:43 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 3.87 | 1-year : | 4.52 |
| Resists | First : | 3.31 | Second : | 3.87 |
| Pivot price | 2.98  |
|||
| Supports | First : | 2.63 | Second : | 2.21 |
| MAs | MA(5) : | 2.98 | MA(20) : | 2.98 |
| MA(100) : | 2.98 |
MA(250) : | 2.86  |
|
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 70 | D(3) : | 70 |
| RSI | RSI(14): 0.5 | |||
| 52-week | High : | 3.84 | Low : | 2.02 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ CO ] has closed above bottom band by 34.9%. Bollinger Bands are 822.4% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 10 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 3.33 - 3.34 | 3.34 - 3.36 |
| Low: | 2.18 - 2.19 | 2.19 - 2.21 |
| Close: | 2.96 - 2.99 | 2.99 - 3.01 |
Global Cord Blood Corporation, together with its subsidiaries, provides umbilical cord blood storage and ancillary services in the People's Republic of China. The company offers cord blood testing, processing, and storage services under the direction of subscribers; and tests, processes, and stores donated cord blood, as well as provides matching services. As of March 31, 2022, it operated three cord blood banks, including one in the Beijing municipality; one in the Guangdong province; and one in the Zhejiang province. The company was formerly known as China Cord Blood Corporation and changed its name to Global Cord Blood Corporation in March 2018. Global Cord Blood Corporation is based in Central, Hong Kong. Global Cord Blood Corporation operates as a subsidiary of Blue Ocean Structure Investment Company Ltd.
Wed, 17 Apr 2024
Global Cord Blood Corp Reschedules EGM - TipRanks.com - TipRanks
Fri, 12 Apr 2024
Global Cord Blood: Fiscal 2Q Earnings Snapshot - Yahoo Canada Shine On
Fri, 12 Apr 2024
Global Cord Blood (NYSE:CO) Now Covered by StockNews.com - MarketBeat
Thu, 04 Apr 2024
Global Cord Blood (NYSE:CO) Research Coverage Started at StockNews.com - MarketBeat
Tue, 19 Mar 2024
Global Cord Blood Corp Announces EGM - TipRanks.com - TipRanks
Wed, 10 Jan 2024
Global Cord Blood and Tissue Banking Industry Gains Traction Amidst Surging M&A Activity and Technological Advances - PR Newswire
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Outperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NYSE
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Diagnostics & Research
|
|
| Shares Out | 134 (M) |
| Shares Float | 36 (M) |
| Held by Insiders | 61.5 (%) |
| Held by Institutions | 22.1 (%) |
| Shares Short | 1,080 (K) |
| Shares Short P.Month | 1,080 (K) |
| EPS | 0.58 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0.15 |
| EPS Est Next Year | 0.17 |
| Book Value (p.s.) | 40.13 |
| Profit Margin | 40.2 % |
| Operating Margin | 48.9 % |
| Return on Assets (ttm) | 4.6 % |
| Return on Equity (ttm) | 10.9 % |
| Qtrly Rev. Growth | -1.8 % |
| Gross Profit (p.s.) | 7.91 |
| Sales Per Share | 9.25 |
| EBITDA (p.s.) | 4.9 |
| Qtrly Earnings Growth | -18.3 % |
| Operating Cash Flow | 614 (M) |
| Levered Free Cash Flow | 379 (M) |
| PE Ratio | 5.06 |
| PEG Ratio | 0 |
| Price to Book value | 0.07 |
| Price to Sales | 0.32 |
| Price to Cash Flow | 0.65 |
| Dividend | 0.07 |
| Forward Dividend | 0 |
| Dividend Yield | 2.6% |
| Dividend Pay Date | 2018-08-23 |
| Ex-Dividend Date | 2018-07-30 |
|
|
|
|
|
|
|
|
|